RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Eastern Cooperative Oncology Group
University of Southern California
Northwestern University
Eli Lilly and Company
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Novartis